Evidence map›Paper›PMID 42500589›Full record

ArticleOncology research2026

Real-World Experience with Venetoclax Therapeutic Drug Monitoring in Acute Myeloid Leukemia: Role of Posaconazole, Correlation with Safety and Efficacy.

Beatrice Sani, Alessandro Cignetti, Marta Leporati, Sara Sommariva, Marco Armenio, Valerio Tenace, Arianna Savi, Johanna Umurungi, Giovanni Fornari, Simone Busso and 6 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Oncology research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Beatrice SaniDepartment of Clinical and Biological Sciences, University of Turin, Turin, Italy.
Alessandro CignettiUniversity Division of Hematology and Cell Therapies, A.O. Ordine Mauriziano di Torino, Turin, Italy.
Marta LeporatiLaboratory of Analytical Chemistry and Kidney Stones, Analysis Laboratory, A.O. Ordine Mauriziano di Torino, Turin, Italy.
Sara SommarivaDepartment of Mathematics, University of Genoa, Genoa, Italy.
Marco ArmenioDepartment of Clinical and Biological Sciences, University of Turin, Turin, Italy.
Valerio TenacePrimisAI, Los Gatos, CA, USA.
Arianna SaviUniversity Division of Hematology and Cell Therapies, A.O. Ordine Mauriziano di Torino, Turin, Italy.
Johanna UmurungiDepartment of Clinical and Biological Sciences, University of Turin, Turin, Italy.
Giovanni FornariDepartment of Clinical and Biological Sciences, University of Turin, Turin, Italy.
Simone BussoLaboratory of Analytical Chemistry and Kidney Stones, Analysis Laboratory, A.O. Ordine Mauriziano di Torino, Turin, Italy.
Alessandra CanevaroLaboratory of Analytical Chemistry and Kidney Stones, Analysis Laboratory, A.O. Ordine Mauriziano di Torino, Turin, Italy.
Igor BisogninLaboratory of Analytical Chemistry and Kidney Stones, Analysis Laboratory, A.O. Ordine Mauriziano di Torino, Turin, Italy.
Silvia MariniDepartment of Clinical and Biological Sciences, University of Turin, Turin, Italy.
Michele PianaDepartment of Mathematics, University of Genoa, Genoa, Italy.
Daniela CilloniDepartment of Clinical and Biological Sciences, University of Turin, Turin, Italy.
Valentina GaidanoUniversity Division of Hematology and Cell Therapies, A.O. Ordine Mauriziano di Torino, Turin, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antineoplastic AgentsBridged Bicyclo Compounds, HeterocyclicDrug MonitoringLeukemia, Myeloid, AcuteSulfonamidesTriazolesAdultAgedAged, 80 and overAntineoplastic Combined Chemotherapy ProtocolsAzacitidineFemaleHumansMaleMiddle AgedTreatment OutcomeAntineoplastic AgentsAzacitidineBridged Bicyclo Compounds, HeterocyclicposaconazoleSulfonamidesTriazolesvenetoclaxAcute myeloid leukemiatherapeutic drug monitoringtoxicityvenetoclax

Identifiers

PMID42500589
PMCPMC13397345

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.